Beyond EGFR TKIs in the Management of Advanced or Metastatic EGFRm NSCLC
Beyond EGFR TKIs in the management of advanced or metastatic EGFRm NSCLC In Conversation Series with • Dr. Shaheenah Dawood (UAE) • Dr. Jacob Sandos
▶︎
Lysosomal Acid Lipase Deficiency (LAL-D) Webinar
▶︎
Evolving Paradigms: The Role of Immunotherapy Across the Lung Cancer Spectrum
▶︎
Transfusion and Beyond: Understanding Supportive Care in MDS
▶︎
RASolute 302 Pancreatic Cancer Study with Daraxonrasib at ASCO 2026 – Dr. Brian Wolpin
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
The Immunotherapy Casebook: Practical Approaches in Frontline Metastatic NSCLC Treatment
▶︎
100+ Undruggable Targets Unlocked Through Parallel MAb Engineering
▶︎
Treatment of Prostate Cancer: Brian J. Moran Distinguished Lecture: Prostate Brachytherapy
▶︎
Emerging OX40/OX40L–Targeted Therapies, Durable AD Control, and Enhanced Quality of Life
▶︎
This Common Food Is Feeding Your Cancer Cells - Dr. William Li
▶︎
How a Public Health Lab is Using AI to Navigate Parasite Identification
▶︎
Menarini Symposium: Strategic Treatment Sequencing and Novel Approaches in 2L+ ER+/HER2– mBC
▶︎
Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC) webinar
▶︎
Updates on 2L Metastatic Breast Cancer Management for PIK3CA/AKT/PTEN Alteration
▶︎
ASCO 2026 Highlights Panel Discussion | Dana-Farber Cancer Institute
▶︎
How Genes Influence Behavior and Mental Health with Dr. Jordan Smoller
▶︎
Ivermectin to Treat Cancer? Get the FACTS
▶︎
The World's Most Important Machine
▶︎
Do This Every Day to Keep Your Arteries Healthy
▶︎